We have shown previously in murine breast and lung cancer models 34, and confirmed in the present mouse sarcoma model, that PLAD retains a level of tumor doxorubicin delivery similar to PLD despite increased uptake in spleen. The gene discussed is GPLD1; the disease is lung cancer.